A mouse model for the autosomal form of Alport syndrome was produced.
These mice develop a progressive glomerulonephritis with microhematuri
a and proteinuria, consistent with the human disease. End-stage renal.
disease develops at similar to 14 weeks of age. TEM analysis of the g
lomerular basement membranes (GEM) during development of renal patholo
gy revealed focal multilaminated thickening and thinning beginning in
the external capillary loops at 4 weeks and spreading throughout the G
EM by 8 weeks. By 14 weeks, half of the glomeruli were fibrotic with c
ollapsed capillaries. Immunofluorescence analysis of the GBM showed th
e absence of type IV collagen alpha-3, alpha-4, and alpha-5 chains and
a persistence of alpha-1 and alpha-2 chains (these chains normally lo
calize to the mesangial matrix). Northern blot analysis using probes s
pecific for the collagen chains illustrate the absence of COL4A3 in th
e knockout, whereas mRNAs for the remaining chains are unchanged. An a
ccumulation of fibronectin, heparan sulfate proteoglycan, laminin-1, a
nd entactin was observed in the GBM of the affected animals. The tempo
ral and spatial pattern of accumulation was consistent with that for t
hickening of the GBM as observed by TEM. Thus, expression of these bas
ement membrane-associated proteins may be involved in the progression
of Alport renal disease pathogenesis. The levels of mRNAs encoding the
basement membrane-associated proteins at 7 weeks were unchanged.